Endo Oxymorphone Immediate-Release Study Cleared By FDA

Agency grants final approval to short-term, repeat-dose study of oxymorphone IR. FDA asks Endo to clarify aspects of its outcomes analysis for a new trial of an extended-release formulation prior to final approval of study protocol.